1-5 of 5
Ling-Ming Tseng
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase Ib Study of Alpelisib or Buparlisib Combined with Tamoxifen Plus Goserelin in Premenopausal Women with HR-Positive HER2-Negative Advanced Breast Cancer

Yen-Shen Lu, Keun Seok Lee, Tsu-Yi Chao, Ling-Ming Tseng, Imjai Chitapanarux, Shin-Cheh Chen, Chien-Ting Liu, Joohyuk Sohn, Jee Hyun Kim, Yuan-Ching Chang, Youngsen Yang, Kanjana Shotelersuk, Kyung Hae Jung, Roberta Valenti, Cassandra Slader, Melissa Gao, Yeon Hee Park
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2021) 27 (2): 408–417.
https://doi.org/10.1158/1078-0432.CCR-20-1008
Published: 19 January 2021
View article titled, A Phase Ib Study of Alpelisib or Buparlisib Combined with Tamoxifen Plus Goserelin in Premenopausal Women with HR-Positive HER2-Negative Advanced Breast Cancer
Open the PDF for A Phase Ib Study of Alpelisib or Buparlisib Combined with Tamoxifen Plus Goserelin in Premenopausal Women with HR-Positive HER2-Negative Advanced Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Bevacizumab Preconditioning Followed by Etoposide and Cisplatin Is Highly Effective in Treating Brain Metastases of Breast Cancer Progressing from Whole-Brain Radiotherapy

Yen-Shen Lu, Tom Wei-Wu Chen, Ching-Hung Lin, Dah-Cherng Yeh, Ling-Ming Tseng, Pei-Fang Wu, Kun-Ming Rau, Bang-Bin Chen, Ta-Chung Chao, Shu-Min Huang, Chiun-Sheng Huang, Tiffany Ting-Fang Shih, Ann-Lii Cheng
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (8): 1851–1858.
https://doi.org/10.1158/1078-0432.CCR-14-2075
Published: 14 April 2015
View article titled, Bevacizumab Preconditioning Followed by Etoposide and Cisplatin Is Highly Effective in Treating Brain Metastases of Breast Cancer Progressing from Whole-Brain Radiotherapy
Open the PDF for Bevacizumab Preconditioning Followed by Etoposide and Cisplatin Is Highly Effective in Treating Brain Metastases of Breast Cancer Progressing from Whole-Brain Radiotherapy in another window
Includes: Supplementary data
Journal Articles

Biomarker Analysis of Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Ixabepilone or Paclitaxel in Early-Stage Breast Cancer

Christine E. Horak, Lajos Pusztai, Guan Xing, Ovidiu C. Trifan, Cristina Saura, Ling-Ming Tseng, Stephen Chan, Rosanne Welcher, David Liu
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (6): 1587–1595.
https://doi.org/10.1158/1078-0432.CCR-12-1359
Published: 14 March 2013
View article titled, Biomarker Analysis of Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Ixabepilone or Paclitaxel in Early-Stage Breast Cancer
Open the PDF for Biomarker Analysis of Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Ixabepilone or Paclitaxel in Early-Stage Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Mitotic Deregulation by Survivin in ErbB2-Overexpressing Breast Cancer Cells Contributes to Taxol Resistance

Jing Lu, Ming Tan, Wen-Chien Huang, Ping Li, Hua Guo, Ling-Ming Tseng, Xiao-hua Su, Wen-Tao Yang, Warapen Treekitkarnmongkol, Michael Andreeff, Fraser Symmans, Dihua Yu
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (4): 1326–1334.
https://doi.org/10.1158/1078-0432.CCR-08-0954
Published: 19 February 2009
View article titled, Mitotic Deregulation by Survivin in ErbB2-Overexpressing Breast Cancer Cells Contributes to Taxol Resistance
Open the PDF for Mitotic Deregulation by Survivin in ErbB2-Overexpressing Breast Cancer Cells Contributes to Taxol Resistance in another window
Includes: Supplementary data
Journal Articles

Preclinical Testing of Clinically Applicable Strategies for Overcoming Trastuzumab Resistance Caused by PTEN Deficiency

Chien-Hsing Lu, Shannon L. Wyszomierski, Ling-Ming Tseng, Meng-Hong Sun, Keng-Hsueh Lan, Christopher L. Neal, Gordon B. Mills, Gabriel N. Hortobagyi, Francisco J. Esteva, Dihua Yu
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (19): 5883–5888.
https://doi.org/10.1158/1078-0432.CCR-06-2837
Published: 01 October 2007
View article titled, Preclinical Testing of Clinically Applicable Strategies for Overcoming Trastuzumab Resistance Caused by PTEN Deficiency
Open the PDF for Preclinical Testing of Clinically Applicable Strategies for Overcoming Trastuzumab Resistance Caused by PTEN Deficiency in another window